A Win For Galectin Therapeutics, Inc.
Tue, Apr 06, 2021 at 05:30 PM
Galectin Therapeutics, Inc. (GALT:NASDAQ) jumped higher at $2.8, representing a gain of 35.3%. On Mon, Apr 05, 2021, GALT:NASDAQ touched a New 2-Week Intraday Low of $2.01. The stock appeared on our News Catalysts scanner on Wed, Mar 31, 2021 at 10:12 AM in the 'INVESTOR UPDATE' category. From Mon, Mar 22, 2021, the stock recorded 44.44% Up Days and 30.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Galectin Therapeutics, Inc. (GALT:NASDAQ)
Galectin Therapeutics Inc is a clinical stage biopharmaceutical company. The Company is engaged in drug research and development to create new therapies for fibrotic disease and cancer.
Top 10 Gainers:
- ENNV (ENNV:NASDAQ), 2641.03%
- RMO (RMO:NYSE), 59.6%
- Galectin Therapeutics, Inc. (GALT:NASDAQ), 35.27%
- SJ (SJ:NASDAQ), 30.38%
- Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT), 29.98%
- GBOX (GBOX:NASDAQ), 28.55%
- Second Sight Medical Products, Inc. (EYES:NASDAQ), 27.43%
- Target Hospitality Corp. (TH:NASDAQ), 24.23%
- FreightCar America, Inc. (RAIL:NASDAQ), 22.87%
- BBQ Holdings, Inc. (BBQ:NASDAQ), 22.38%